BeyondSpring is trading at $0.49, up 5.89%, with no fresh company-specific announcement identified to explain the October 28 move. - The latest listed company news remains the earlier FDA Fast Track and DUBLIN-4 update. - Biotech sector strength offers context, with XBI up 2.18%, but does not confirm a direct cause; major-index moves are modest. - No trading-volume figure is verified here.